Daewoong Pharma Q3 Standalone Operating Profit Rises 43.5% Year on Year
Bitget2026/11/03 23:44- Daewoong Pharma’s third-quarter 2026 standalone operating profit rose 43.5% year over year to KRW 76.83 billion.
- Revenue increased 17.1% from a year earlier to KRW 415.84 billion.
- Net profit climbed 9.9% year over year to KRW 47.34 billion.
- Sequentially, operating profit fell 0.4%; net profit dropped 31.8%.
- For the first nine months of 2026, operating profit increased 14.8% to KRW 181.38 billion.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Jensen Huang's influence surpasses that of Nvidia— and that's exactly the problem
Jensen Huang has been the key driving force behind the massive expansion of AI infrastructure, with his personal credibility and authoritative decision-making deeply embedded in the narrative of the global tech market’s rise over the past three years. Now, as scandals emerge, Nvidia’s trading team is expected to become more conservative and slow down external financing commitments, which undoubtedly worsens the situation for neoclouds already facing tight funding.
Crypto prices
More
